Apixaban {Eliquis} Market, By Dosage form, By Distribution channel, By Route of administration, and By Region - Market Trends, Analysis, and Forecast till 2030

COVINA, CALIFONIA, UNITED STATE, April 17, 2023/EINPresswire.com/ -- The Apixaban (Eliquis) market refers to the market for a type of anticoagulant medication that is used to prevent blood clots and reduce the risk of stroke and other cardiovascular events in patients with atrial fibrillation, deep vein thrombosis, and pulmonary embolism.

Apixaban works by inhibiting the activity of a clotting factor in the blood called Factor Xa, which helps to prevent the formation of blood clots. It is typically administered orally in tablet form, and is often used as an alternative to other anticoagulant medications such as warfarin.

The Apixaban market is driven by factors such as the increasing prevalence of cardiovascular diseases, the growing demand for more effective and safer anticoagulant medications, and the expanding use of apixaban for new indications such as the prevention of venous thromboembolism in hospitalized patients.The market is also influenced by factors such as increasing competition from other anticoagulant medications, the high cost of apixaban compared to other treatments, and the need for ongoing monitoring of patients taking apixaban to ensure safety and efficacy.

Despite these challenges, the Apixaban market is expected to experience growth in the coming years, driven by factors such as increasing adoption of the drug in emerging markets, ongoing research and development efforts to expand the use of apixaban for new indications, and the growing demand for safer and more effective anticoagulant medications.Overall, the Apixaban market represents an important area of focus for the global healthcare industry, as the need for effective anticoagulant treatments continues to grow, particularly in the context of an aging global population and increasing rates of cardiovascular disease.

Request Sample Pages:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4737

Analyst View:
The Apixaban (Eliquis) market is expected to experience significant growth in the coming years, driven by several factors such as the increasing prevalence of cardiovascular diseases, the growing demand for safer and more effective anticoagulant medications, and the expanding use of apixaban for new indications.

One of the key advantages of apixaban is its safety profile, which has been demonstrated in several clinical trials. Unlike other anticoagulant medications such as warfarin, apixaban does not require regular blood monitoring or dietary restrictions, making it a more convenient treatment option for many patients.Another factor driving the market is the expanding use of apixaban for new indications. In addition to its approved uses for atrial fibrillation, deep vein thrombosis, and pulmonary embolism, apixaban is also being studied for the prevention of stroke and other cardiovascular events in patients with other conditions such as heart failure and peripheral artery disease.

However, the Apixaban market also faces challenges such as increasing competition from other anticoagulant medications and the high cost of apixaban compared to other treatments. The need for ongoing monitoring of patients taking apixaban to ensure safety and efficacy may also limit its adoption in some settings.Overall, the Apixaban market represents an important area of focus for the global healthcare industry, as the need for effective and safe anticoagulant treatments continues to grow. With ongoing research and development efforts and expanding use for new indications, the market is expected to experience growth and innovation in the coming years.

Scope of the Report:
1. Global Apixaban {Eliquis} Market, By Dosage form, 2020 – 2030, (US$ Mn)
>Tablets
• Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
• Y-o-Y Growth Analysis (%), 2020 – 2030
• Segment Trends
>Capsules
• Overview
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
2. Global Apixaban {Eliquis} Market, By Distribution Channel, 2020 – 2030, (US$ Mn)
>Hospital
• Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
• Y-o-Y Growth Analysis (%), 2020 – 2030
• Segment Trends
>Retail pharmacies
• Overview
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
>Online pharmacies
• Overview
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
>Clinics
• Overview
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
3. Global Apixaban {Eliquis} Market, By Route of administration, 2020 – 2030, (US$ Mn)
>Oral
• Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
• Y-o-Y Growth Analysis (%), 2020 – 2030
• Segment Trends
>Injectable
• Overview
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030

Download PDF Brochure:
https://www.prophecymarketinsights.com/market_insight/Insight/request-pdf/4737

Competitive Analysis:
• Roche
• Bristol-Myers Squibb
• Siemens
• Portola Pharmaceuticals
• C. H. Boehringer Sohn
• Pfizer
• CoaguSense
• Alere

Other Trending Reports:
Pharmaceutical Logistics Market: By Type (Cold Chain and Non Cold Chain), By Technology (Logistics (Sea Freight, Airfreight, Rail Freight, Overland, and Integrated) and Procedures (Picking, Storage, Retrieval Systems, and Handling Systems), By Application (Chemical Pharma, Bio-Pharma, and Specialized Pharma), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis, and Forecast till 2029

Antidepressants Market: By Product (Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI), and Other Products), By Depressive Disorder (Major Depressive Disorder, Obsessive-compulsive Disorder (OCD), Generalized Anxiety Disorder (GAD), Panic Disorder (PD), and Other Depressive Disorders), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis, and Forecast till 2029

Shweta Raskar
Prophecy Market Insights
+ +1 860 531 2574
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.